Joinn’s ‘jumping’ monkey market hides core weakness
Despite announcing a sharp profit surge, the lab animal provider’s stock ticked up by just a muted 3% over the next three trading days Key Takeaways: Joinn Laboratories has built…
BRIEF: Joinn Lab swings to red on lower revenue, falling gross margin
Joinn Laboratories (China) Co. Ltd. (6127.HK; 603127.SH), China’s leading non-clinical contract research organization (CRO), said on Wednesday its revenue fell 15.5% to 486 million yuan ($68.3 million) in the third quarter,…
FAST NEWS: Joinn Laboratories spents $3.7 million on share buyback
The Latest: Joinn Laboratories (China) Co. Ltd. (6127.HK; 603127.SH), China’s leading non-clinical contract research organization (CRO), said on Monday that since announcing a plan on Mar. 27 to repurchase its A…
FAST NEWS: Joinn Lab profit plunges, sending shares to 52-week low
The latest: Joinn Laboratories (China) Co. Ltd. (6127.HK; 603127.SH), China’s leading non-clinical contract research organization (CRO), announced on Tuesday it expects to report a net profit of 311 million ($43.8…
FAST NEWS: Joinn Lab profit slumps on falling lab monkey prices
The latest: Joinn Laboratories (China) Co. Ltd. (6127.HK; 603127.SH), China’s leading non-clinical contract research organization (CRO), announced on Monday its revenue rose 15.1% to 575 million yuan ($78.6 million) in the third quarter,…
Joinn profits slide as lab monkey build-up backfires
The leading provider of pre-clinical drug research has predicted its first-half profits will plummet between 70% and 80% due to the falling value of its lab animals Key Takeaways: Joinn…
Cash-strapped Viva Biotech sells stake and plans spinoff
The biotech has gained a capital injection from Temasek and a major Chinese investor, but the deal has not boosted investor confidence Key Takeaways: As well as tapping strategic investors,…